The Rapid Plasma Reagin (RPR) test is a blood test used to screen for syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The RPR test is a non-treponemal test, meaning it does not directly detect the presence of the syphilis bacterium but instead detects antibodies produced by the body in response to the infection.
The global market for Plasma Reagin Rapid (RPR) Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global market for the Plasma Reagin Rapid (RPR) test was experiencing steady growth due to the increasing prevalence of sexually transmitted infections (STIs) and the rising awareness about the importance of early detection and treatment. The RPR test is a widely used screening tool for syphilis, one of the most common STIs globally. North America held a significant share in the global RPR test market, driven by a high prevalence of STIs and well-established healthcare infrastructure. The region's focus on preventive healthcare and routine STI testing contributed to market growth. Europe was another prominent market for RPR tests, with increasing awareness about STI testing and government initiatives to control syphilis transmission. The Asia-Pacific region witnessed rapid market growth due to the large population, rising awareness about STIs, and efforts to improve healthcare access in developing countries.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Reagin Rapid (RPR) Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasma Reagin Rapid (RPR) Test by region & country, by Type, and by Application.
The Plasma Reagin Rapid (RPR) Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Reagin Rapid (RPR) Test.
麻豆原创 Segmentation
By Company
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type:
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Reagin Rapid (RPR) Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Plasma Reagin Rapid (RPR) Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Plasma Reagin Rapid (RPR) Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Plasma Reagin Rapid (RPR) Test Product Introduction
1.2 Global Plasma Reagin Rapid (RPR) Test 麻豆原创 Size Forecast
1.3 Plasma Reagin Rapid (RPR) Test 麻豆原创 Trends & Drivers
1.3.1 Plasma Reagin Rapid (RPR) Test Industry Trends
1.3.2 Plasma Reagin Rapid (RPR) Test 麻豆原创 Drivers & Opportunity
1.3.3 Plasma Reagin Rapid (RPR) Test 麻豆原创 Challenges
1.3.4 Plasma Reagin Rapid (RPR) Test 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma Reagin Rapid (RPR) Test Players Revenue Ranking (2023)
2.2 Global Plasma Reagin Rapid (RPR) Test Revenue by Company (2019-2024)
2.3 Key Companies Plasma Reagin Rapid (RPR) Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies Plasma Reagin Rapid (RPR) Test Product Offered
2.5 Key Companies Time to Begin Mass Production of Plasma Reagin Rapid (RPR) Test
2.6 Plasma Reagin Rapid (RPR) Test 麻豆原创 Competitive Analysis
2.6.1 Plasma Reagin Rapid (RPR) Test 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Plasma Reagin Rapid (RPR) Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Reagin Rapid (RPR) Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies Test
3.1.2 Immunofluorescence Test
3.1.3 Fluorescent Treponemal Antibody Absorption Test
3.1.4 T. Pallidum Hemagglutination Assay
3.2 Global Plasma Reagin Rapid (RPR) Test Sales Value by Type
3.2.1 Global Plasma Reagin Rapid (RPR) Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasma Reagin Rapid (RPR) Test Sales Value, by Type (2019-2030)
3.2.3 Global Plasma Reagin Rapid (RPR) Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostics Laboratories
4.1.4 Others
4.2 Global Plasma Reagin Rapid (RPR) Test Sales Value by Application
4.2.1 Global Plasma Reagin Rapid (RPR) Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasma Reagin Rapid (RPR) Test Sales Value, by Application (2019-2030)
4.2.3 Global Plasma Reagin Rapid (RPR) Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Plasma Reagin Rapid (RPR) Test Sales Value by Region
5.1.1 Global Plasma Reagin Rapid (RPR) Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasma Reagin Rapid (RPR) Test Sales Value by Region (2019-2024)
5.1.3 Global Plasma Reagin Rapid (RPR) Test Sales Value by Region (2025-2030)
5.1.4 Global Plasma Reagin Rapid (RPR) Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
5.2.2 North America Plasma Reagin Rapid (RPR) Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
5.3.2 Europe Plasma Reagin Rapid (RPR) Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
5.4.2 Asia Pacific Plasma Reagin Rapid (RPR) Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
5.5.2 South America Plasma Reagin Rapid (RPR) Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
5.6.2 Middle East & Africa Plasma Reagin Rapid (RPR) Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma Reagin Rapid (RPR) Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasma Reagin Rapid (RPR) Test Sales Value
6.3 United States
6.3.1 United States Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.3.2 United States Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.4.2 Europe Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.5.2 China Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.6.2 Japan Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.7.2 South Korea Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.8.2 Southeast Asia Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasma Reagin Rapid (RPR) Test Sales Value, 2019-2030
6.9.2 India Plasma Reagin Rapid (RPR) Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasma Reagin Rapid (RPR) Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Profile
7.1.2 Cardinal Health Main Business
7.1.3 Cardinal Health Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.1.4 Cardinal Health Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.1.5 Cardinal Health Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.2.4 Abbott Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 BD
7.3.1 BD Profile
7.3.2 BD Main Business
7.3.3 BD Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.3.4 BD Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Holding Recent Developments
7.4 Roche Holding
7.4.1 Roche Holding Profile
7.4.2 Roche Holding Main Business
7.4.3 Roche Holding Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.4.4 Roche Holding Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Holding Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Siemens
7.6.1 Siemens Profile
7.6.2 Siemens Main Business
7.6.3 Siemens Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.6.4 Siemens Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Recent Developments
7.7 SEKISUI Diagnostics
7.7.1 SEKISUI Diagnostics Profile
7.7.2 SEKISUI Diagnostics Main Business
7.7.3 SEKISUI Diagnostics Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.7.4 SEKISUI Diagnostics Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.7.5 SEKISUI Diagnostics Recent Developments
7.8 Immunostics
7.8.1 Immunostics Profile
7.8.2 Immunostics Main Business
7.8.3 Immunostics Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.8.4 Immunostics Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.8.5 Immunostics Recent Developments
7.9 Novacyt
7.9.1 Novacyt Profile
7.9.2 Novacyt Main Business
7.9.3 Novacyt Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.9.4 Novacyt Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.9.5 Novacyt Recent Developments
7.10 Arlington Scientific
7.10.1 Arlington Scientific Profile
7.10.2 Arlington Scientific Main Business
7.10.3 Arlington Scientific Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.10.4 Arlington Scientific Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.10.5 Arlington Scientific Recent Developments
7.11 Lorne Laboratories
7.11.1 Lorne Laboratories Profile
7.11.2 Lorne Laboratories Main Business
7.11.3 Lorne Laboratories Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.11.4 Lorne Laboratories Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.11.5 Lorne Laboratories Recent Developments
7.12 Meridian Bioscience
7.12.1 Meridian Bioscience Profile
7.12.2 Meridian Bioscience Main Business
7.12.3 Meridian Bioscience Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.12.4 Meridian Bioscience Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.12.5 Meridian Bioscience Recent Developments
7.13 Bio-Rad Laboratories
7.13.1 Bio-Rad Laboratories Profile
7.13.2 Bio-Rad Laboratories Main Business
7.13.3 Bio-Rad Laboratories Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.13.4 Bio-Rad Laboratories Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.13.5 Bio-Rad Laboratories Recent Developments
7.14 Mediclone Biotech
7.14.1 Mediclone Biotech Profile
7.14.2 Mediclone Biotech Main Business
7.14.3 Mediclone Biotech Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.14.4 Mediclone Biotech Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.14.5 Mediclone Biotech Recent Developments
7.15 Newmarket Biomedical
7.15.1 Newmarket Biomedical Profile
7.15.2 Newmarket Biomedical Main Business
7.15.3 Newmarket Biomedical Plasma Reagin Rapid (RPR) Test Products, Services and Solutions
7.15.4 Newmarket Biomedical Plasma Reagin Rapid (RPR) Test Revenue (US$ Million) & (2019-2024)
7.15.5 Newmarket Biomedical Recent Developments
8 Industry Chain Analysis
8.1 Plasma Reagin Rapid (RPR) Test Industrial Chain
8.2 Plasma Reagin Rapid (RPR) Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma Reagin Rapid (RPR) Test Sales Model
8.5.2 Sales Channel
8.5.3 Plasma Reagin Rapid (RPR) Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
听
听
*If Applicable.
